Skip to main content
Journal of Young Pharmacists : JYP logoLink to Journal of Young Pharmacists : JYP
. 2013 Jul 8;5(2):60–63. doi: 10.1016/j.jyp.2013.06.004

Inverted U shaped effect of nicotine on the severity of depressive symptoms: A population-based survey

Ammar W Ashor 1,
PMCID: PMC3758084  PMID: 24023456

Abstract

Objectives

To investigate whether that nicotine concentration represented by the degree of smoking dependence variably influence the rate and severity of depressive symptoms.

Methods

Cross-sectional, analytical study, involving 300 medical students selected by random sampling techniques were asked to complete a questionnaire contains three parts: demographic information, Beck Depression Inventory with cutoff point for depression is 17 and the Fagerström Test for Nicotine dependence with cutoff point for severe dependence is five.

Results

A total of 233 medical students completed the questionnaire; their mean age was (21.38 ± 1.74). The rate of smoking was 22.7% while that of depression was 32.2%. Low dependent smokers in contrast to other groups of smokers and non-smokers display the lowest rate of depressive symptoms (15%), while the highest rate recorded among severely dependent smokers (71.4%, p = 0.0001). After adjustment of other risk factors, regression analysis reveal that severe dependent smokers associated with 12.5 odds of depressive symptoms than non-smokers (p = 0.0001, C.I. 4.10-38.29).

Conclusion

In comparison with light and moderate smokers, heavy smokers demonstrate higher risk of depressive symptoms in medical students.

Keywords: Beck Depression Inventory, Nicotine dependence, Medical students, Tobacco smoking, Iraq

1. Introduction

Many epidemiological studies have shown a strong association of smoking with depression,1,2 it has been found that about 50% of the individuals suffering from depression reported to be smokers, on the other hand, regular smokers display more depressive symptoms, more frequent and severe episodes of depression and higher rate of suicidal ideation.3

The common explanation of this association is the self-medication hypothesis, which state that depressed patients smoke to relieve their symptoms.4 This hypothesis was constructed on the reports of smokers who experience an improved sense of well-being, greater calm, better attention, and superior ability to concentrate after smoking.5 Additionally, nicotine increases the secretion of dopamine in the limbic system which may also contribute to the euphoria and addictive potential of nicotine.6

However, recently the self-medication hypothesis undergoes significant criticism because of the many published prospective studies which prove that smoking increase the risk of depression and not the reverse.7,8 These studies explain the previous reported improvement among smokers as following: smoking only generates mood changes in nicotine-deprived smokers, but these only represents the restoration of normal moods, and it's found that when non-deprived smokers had a cigarette, their mood ratings remain unaltered.9

Many factors implicated in the variability of nicotine effects in the brain like nicotine dose, duration and frequency of administration.10-12 In the present study, we propose that there is diverse influence of nicotine on mood according to the level of dependence; it means that low nicotine exposure may produce positive effects while high dose of nicotine (severe nicotine dependence) associated with negative emotional effect and depressive symptoms.

The aim of the present study is to investigate whether nicotine concentration represented by the degree of smoking dependence has variable influence on the rate and severity of depressive symptoms among medical students.

2. Methods

Study design: a cross-sectional analytical study, conducted on medical students in the college of medicine, University of Al-Mustansiriya, Baghdad, Iraq from October to December 2011. The study follows the Helsinki Declaration regarding humans involved in clinical trials and was approved by the local scientific and ethical committee in the medical college.

Participants: students were voluntarily invited to participate during their attendance in the laboratory, sessions, or lectures. First, students informed about the anonymity of the questionnaire and that the information is confidential, then verbal consent were taken from those who were willing to participate.

Measures: the questionnaire composed of three parts:

  • General demographic questions: this part contains general information about students (age, sex, stage of study).

  • Beck Depression Inventory-II: this questionnaire composed of 21 items, assessing many symptoms that occur in depressive patients like (sadness, pessimism, guilt, fatigue, anorexia, crying, suicidal thoughts, etc.); these symptoms were phrased in four alternative descriptions (four statements). Every set of statements was written in the order of increasing distress. The participants had to select, for each item, the response alternative that correspond best to their situation for now and the past week. The total score was obtained by adding the values of all items, each ranged from 0 to 3, with the total score ranged from 0 to 63,13 and a cut score of either 17 or 18 provide the best balance between sensitivity and specificity.14

  • Fagerström test for nicotine dependence (FTND): those who were reported to be smokers then fill the FTND questionnaire in addition to questioning their age of starting to smoke. Recent systemic review of the FTND questionnaire found that the reliability of this scale ranged from 0.65 to 0.91 with sensitivity (0.75) and specificity of (0.80) and the Cronbach's alpha of internal consistency ranged 0.55 to 0.74.15 The FTND scale composed of six items questions (time taken for the first cigarette after waking up, ability to refrain from smoking in forbidden places, how many cigarettes smoked per day, etc.). The total score for the FTND ranged between 0 and 10; a score ranged from 0 to 3 regarded as mild dependence, while score of 4-5 as moderate dependence and scoring higher than 5 considered as severe smoking dependence.

2.1. Statistical analysis

Analyses of the results were done by using PASW Statistics 18 software (SPSS Inc., Chicago, IL). The numerical variables expressed as mean ± SD and analyzed by using independent sample t-test for the comparison of two independent groups or the Analysis of Variance test (ANOVA) for the comparison of more than two groups (Tukey test for post hoc analysis). Categorical variables expressed as number (%) and analyzed with Pearson's chi-squared test for univariable analysis, and multivariable analysis done to find the association between groups in adjustment for sex, age, and stage of the students using logistic regression analysis, Odd ratio and its class interval were reported; in all the above tests a p value less than 0.05 were considered as statistically significant.

3. Results

Two hundred and thirty three medical students participated in the study; their age ranged from 18 to 26 with a mean of (21.38 ± 1.74), female represents (43.6%) of all the students. Smoking prevalence was (22.7%), their age of onset of smoking ranged from 14 to 23 years. The range of the students score on Beck Depression Inventory ranged between 2 and 41, and (32.2%) of all medical students demonstrate depressive symptoms. The distribution of the participants regarding years of study and their smoking status with other parameters presented in Table 1 below.

Table 1.

Participants demographic characteristics.

Demographic characteristics (mean ± SD) Number (%) [total number of participants = 233]
Age (21.38 ± 1.74)
Gender
  • Male

131 (56.2)
  • Female

102 (43.6)
Stage
  • First

34 (14.6)
  • Second

44 (18.9)
  • Third

44 (18.9)
  • Fourth

36 (15.5)
  • Fifth

39 (16.7)
  • Sixth

36 (15.5)
Non-smokers 180 (77.3)
Smokers 53 (22.7)
  • Low dependence

20 (8.6)
  • Moderate dependence

12 (5.2)
  • Severe dependence

21 (9.0)
Age of start smoking (17.36 ± 2.43)
Beck Depression Inventory (13.63 ± 7.93)
  • <17

158 (67.8)
  • ≥17

75 (32.2)

Depressed students significantly older, start smoking at earlier age, having higher FTND score than non-depressed (see Table 2). Female students demonstrate significantly higher rate of depression than male students (42.2% vs. 24.4% for females and males respectively, p = 0.004).

Table 2.

Comparison between non-depressed and depressed students regarding their age, Beck Depression Inventory (BDI), age of start smoking and their Fagerström test for nicotine dependence (FTND).

Non-depressed (n = 158) mean ± SD Depressed (n = 75) mean ± SD P value Class interval
Age 21.21 ± 1.73 21.75 ± 1.72 0.027* 0.061-1.015
BDI 9.03 ± 3.82 23.33 ± 5.07 0.038* 13.12-15.62
Age of smoking 18.00 ± 2.30 16.52 ± 2.37 0.026* 0.180-2.777
FTND score 3.50 ± 2.68 6.26 ± 2.76 0.001* 1.246-4.276

*Significant difference between groups using independent sample t-test.

Table 3 demonstrate that severe dependent smokers start smoking at earlier age (p = 0.001) and have higher mean depression score (p = 0.001) than other groups. Low dependent smokers (Fig. 1) in contrast to other groups of smokers and non-smokers demonstrate the lower rate (15%) of depressive symptoms (p = 0.0001), while the highest rate seen among severely dependent smokers (71.4%).

Table 3.

Comparison between students smoking status, FTND, and BDI.

Non-smokers (N = 180) Low dependence (N = 20) Moderate dependence (N = 12) Severe dependence (N = 21)
Age 21.3 ± 1.7 21.6 ± 2.2 21.5 ± 1.4 22.2 ± 1.2
Age of smoking 18.5 ± 2.7 18.1 ± 1.9 15.9 ± 1.6
FTND score 1.5 ± 1.1 4.5 ± 0.5 7.9 ± 1.4
BDI 12.9 ± 7.7 12.2 ± 6.5 16.0 ± 7.4 19.9 ± 8.7

FTND: Fagerström Test For Nicotine Dependence; BDI: Beck Depression Inventory. All values are mean ± SD, *P < 0.001 compare to low and moderate dependence (One-way ANOVA followed by Tukey's post hoc test).

Fig. 1.

Fig. 1

The rate of depression among the different categories of smokers.

In Table 4, univariate logistic regression analysis done using depression as dependent variable, demonstrate that age, sex, age of onset of smoking and the FTND score significantly associated with depression. Female students display 2.25 times higher odds of depressive symptoms than their male peer students. In the same table mentioned before, severe smoking dependence has 6.15 times higher odds of depressive symptoms than non-smokers.

Table 4.

Univariable association of the Demographic participants' characteristics.

Wald P value Odds ratio Class interval
Age 4.774 0.029* 1.20 1.02-1.42
Sex 8.105 0.004* 2.25 1.28-3.94
Stage 0.653 0.419 1.07 0.91-1.26
Age of smoking 4.554 0.033* 0.752 0.58-0.98
FTND score 9.419 0.002* 1.427 1.14-1.79
Non-smokers 15.710
Low dependence 1.659 0.198 0.434 0.122-1.55
Moderate dependence 0.861 0.353 1.758 0.534-5.79
Severe dependence 12.681 0.0001* 6.154 2.26-16.73

FTND: Fagerström Test for Nicotine Dependence; BDI: Beck Depression Inventory cutoff value (≥17) among medical students.

*P < 0.05 for the logistic regression analysis comparing depressed with non-depressed students for the above variables.

Multivariate logistic regression analysis using depression as dependent variable with age, age of smoking and sex as covariate, demonstrate that severe smoking dependence significantly associated with depression with odds of 12.33 (p = 0.007, C.I: 1.98-76.61) in comparison with non-smokers.

4. Discussion

Nicotine follow typically an 'inverted U' effects on cognition and behavior, i.e. nicotine self-administration (positive re-enforcing effect) require optimum doses near the top of the inverted U, but if the dose was too high, aversive effects dominated.10,16

In the present study, low dependent smokers (low nicotine) display lower odds of depressive symptoms than non-smokers and other categories of smokers, while severely dependent smokers (high nicotine intake) associated with high risk of depressive symptoms than the other groups after adjustment of other risk factors.

Animal studies demonstrated that nicotine had antidepressant effects comparable to currently used antidepressant agents.17 Besides, intravenous administration of nicotine have been shown to creates a sense of euphoria that is hard to distinguish from the effects of other drugs of abuse such as cocaine and alcohol,5 furthermore, cigarette smoke contains substances that have Monoamine oxidase enzyme inhibition which adds to the antidepressant effect as well.18

However, Bolam et al, in their study, claimed that there is evidence of dose-response relationship between number of cigarettes smoked per day and depression (OR = 1.46, C.I. 1.13-1.89).19 Furthermore, Boden et al proved that increasing level of nicotine dependence were significantly associated with increasing in the rates of depressive symptoms.7

Moreover, Kang and Lee in their longitudinal study demonstrated that smoking less than ten cigarette per day associated with 1.5 odds of depressive symptoms while smoking more than 40 cigarette per day had 7.3 odds of depression in comparison with non-smokers.20

Light smokers reported lower perceived stress, fewer symptoms of depression and greater positive affect in comparison with heavy smokers.21 Heavy smokers reported higher rate of stress than non- and light smokers,22 and it is found that suicide behavior was more frequent among heavy smokers than among light smokers.23

Several factors collaborate to the depressant effect of high nicotine concentration represented by severe smoking dependence. First, nicotine injected to animals with low circulating levels of nicotine results in stimulation of nicotinic receptors and release of dopamine, while injecting nicotine to animals with blood nicotine concentration similar to those found in the plasma of habitual smokers for much of the day fails to stimulate many of dopamine neurons in the reward center.12

Second, continuous administration of nicotine associated with reduction in the serotonin and GABA transmitters, these transmitters important in the regulation of mood.6,24

Third, heavy smokers have higher concentration of stress hormones (CRF, ACTH, corticosterone) than light and non-smokers, these hormones implicated in the causation of depression.22

Fourth, the cholinergic hypothesis of depression, this state that high acetylcholine may be responsible for the onset of depression. The supporting evidence of this theory includes the following: elevated choline level in the brain of depressed patients, physostigmine (acetylcholine agonist) exacerbate depressed mood while scopolamine (acetylcholine antagonist) found to be effective antidepressant.23

The present study comprises many limitations. First, it is cross-sectional study, therefore causal association between the degree of tobacco dependence and depressive symptoms difficult to be elucidated. Second, self-reported measurement of nicotine dependence and depression enclose many problems like subjectivity and bias in reporting. Third, small sample size which is not representative to the whole population (single college), therefore this put limits on generalization of the results.

Prospective studies are vital to further elucidate the relationship between the degree of smoking dependence and depression, these studies required to be more objective by measuring serum cotinine level as well as implementing diagnostic interview as a mean for diagnosis and follow up of depressed patients.

5. Conclusions

Despite the above limitations, the present study may partially explain the controversy regarding the relationship between smoking and depression by adopting the U shaped behavior of nicotine in the brain. This is done through the finding that severe dependent smokers associated with very high risk of depression in comparison with other groups.

Conflicts of interest

The author has none to declare.

Acknowledgment

Deep thanks and gratitude to Dr. Ali K. Chelab and Ahmad Natiq (4th year Medical Student) for their help in the distribution and collection of the questionnaire.

References

  • 1.Farrell M., Howes S., Bebbington P. Nicotine, alcohol and drug dependence, and psychiatric comorbidity - results of a national household survey. Int Rev Psychiatry. 2003;15:50–56. doi: 10.1080/0954026021000045949. [DOI] [PubMed] [Google Scholar]
  • 2.Grant B.F., Hasin D.S., Chou S.P., Stinson F.S., Dawson D.A. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61:1107–1115. doi: 10.1001/archpsyc.61.11.1107. [DOI] [PubMed] [Google Scholar]
  • 3.Kalman D., Morissette S.B., George T.P. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict. 2005;14:106–123. doi: 10.1080/10550490590924728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Leonard S., Adler L.E., Benhammou K. Smoking and mental illness. Pharmacol Biochem Behav. 2001;70:561–570. doi: 10.1016/s0091-3057(01)00677-3. [DOI] [PubMed] [Google Scholar]
  • 5.Quattrocki E., Baird A., Yurgelun-Todd D. Biological aspects of the link between smoking and depression. Harv Rev Psychiatry. 2000;8:99–110. [PubMed] [Google Scholar]
  • 6.Aubin H.J., Rollema H., Svensson T.H., Winterer G. Smoking, quitting, and psychiatric disease: a review. Neurosci Biobehav Rev. 2012;36:271–284. doi: 10.1016/j.neubiorev.2011.06.007. [DOI] [PubMed] [Google Scholar]
  • 7.Boden J.M., Fergusson D.M., Horwood L.J. Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br J Psychiatry. 2010;196:440–446. doi: 10.1192/bjp.bp.109.065912. [DOI] [PubMed] [Google Scholar]
  • 8.Dierker L.C., Avenevoli S., Stolar M., Merikangas K.R. Smoking and depression: an examination of mechanisms of comorbidity. Am J Psychiatry. 2002;159:947–953. doi: 10.1176/appi.ajp.159.6.947. [DOI] [PubMed] [Google Scholar]
  • 9.Parrott A.C. Nicotine psychobiology: how chronic-dose prospective studies can illuminate some of the theoretical issues from acute-dose research. Psychopharmacology (Berl) 2006;184:567–576. doi: 10.1007/s00213-005-0294-y. [DOI] [PubMed] [Google Scholar]
  • 10.Picciotto M.R. Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci. 2003;24:493–499. doi: 10.1016/S0165-6147(03)00230-X. [DOI] [PubMed] [Google Scholar]
  • 11.Benowitz N.L. Nicotine addiction. N Engl J Med. 2010;362:2295–2303. doi: 10.1056/NEJMra0809890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Balfour D.J. The psychobiology of nicotine dependence. Eur Respir Rev. 2008;17:172–181. [Google Scholar]
  • 13.Cusin C., Yang H., Yeung A., Fava M. Rating Scales for Depression. In: Baer L., Blais M.A., editors. Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health. Humana Press; New York: 2010. pp. 8–p24. [Google Scholar]
  • 14.Nuevo R., Lehtinen V., Reyna-Liberato P.M., Ayuso-Mateos J.L. Usefulness of the Beck Depression Inventory as a screening method for depression among the general population of Finland. Scand J Public Health. 2009;37:28–34. doi: 10.1177/1403494808097169. [DOI] [PubMed] [Google Scholar]
  • 15.Meneses-Gaya I.C., Zuardi A.W., Loureiro S.R., Crippa J.A. Psychometric properties of the Fagerström test for nicotine dependence. J Bras Pneumol. 2009;35:73–82. doi: 10.1590/s1806-37132009000100011. [DOI] [PubMed] [Google Scholar]
  • 16.Heishman S.J., Kleykamp B.A., Singleton E.G. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) 2010;210:453–469. doi: 10.1007/s00213-010-1848-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Andreasen J.T., Henningsen K., Bate S., Christiansen S., Wiborg O. Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline. J Psychopharmacol. 2011;25:1134–1141. doi: 10.1177/0269881110391831. [DOI] [PubMed] [Google Scholar]
  • 18.Bacher I., Houle S., Xu X. Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. Arch Gen Psychiatry. 2011;68:817–826. doi: 10.1001/archgenpsychiatry.2011.82. [DOI] [PubMed] [Google Scholar]
  • 19.Bolam B., West R., Gunnell D. Does smoking cessation cause depression and anxiety? Findings from the ATTEMPT cohort. Nicotine Tob Res. 2011;13:209–214. doi: 10.1093/ntr/ntq244. [DOI] [PubMed] [Google Scholar]
  • 20.Kang E., Lee J. A longitudinal study on the causal association between smoking and depression. J Prev Med Public Health. 2010;43:193–204. doi: 10.3961/jpmph.2010.43.3.193. [DOI] [PubMed] [Google Scholar]
  • 21.Businelle M.S., Kendzor D.E., Costello T.J. Light versus heavy smoking among African American men and women. Addict Behav. 2009;34:197–203. doi: 10.1016/j.addbeh.2008.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Richards J.M., Stipelman B.A., Bornovalova M.A., Daughters S.B., Sinha R., Lejuez C.W. Biological mechanisms underlying the relationship between stress and smoking: state of the science and directions for future work. Biol Psychol. 2011;88:1–12. doi: 10.1016/j.biopsycho.2011.06.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dome P., Lazary J., Kalapos M.P., Rihmer Z. Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev. 2010;34:295–342. doi: 10.1016/j.neubiorev.2009.07.013. [DOI] [PubMed] [Google Scholar]
  • 24.Laviolette S.R., Van der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci. 2004;5:55–65. doi: 10.1038/nrn1298. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Young Pharmacists : JYP are provided here courtesy of Elsevier

RESOURCES